Funding Opportunity Announcement (FOA) Number
| |
Companion Funding Opportunity
|
RFA-MH-14-211, R01 Research Project Grant
RFA-MH-14-212, R34 Clinical Trial Planning Grant Program
|
Catalog of Federal Domestic Assistance (CFDA) Number(s)
|
93.242
|
Funding Opportunity Purpose
|
Given the highly disruptive and disabling nature of psychotic disorders, early intervention has been recommended as a means of preventing psychosis onset among at-risk individuals, as well as averting other adverse outcomes such as mood syndromes, substance abuse disorders, and functional decline in social, academic, and vocational domains. This funding opportunity announcement, along with the companion announcements, aims to support research that will inform a step-wise approach to early psychosis intervention in the United States. The goals of this initiative are to encourage applications that (1) test the effectiveness of interventions that target symptomatic and functional difficulties associated with clinical risk states for psychosis; (2) test hypotheses regarding mediators/mechanisms of action of these interventions; (3) create an evidence base to inform stepped-care models of early psychosis intervention; and (4) determine the feasibility for implementing such approaches in community-based treatment settings.
|
Key Dates
Posted Date
|
August 7, 2013
|
Open Date (Earliest Submission Date)
|
December 6, 2013
|
Letter of Intent Due Date(s)
|
December 6, 2013
|
Application Due Date(s)
|
January 6, 2014, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
|
No comments:
Post a Comment